Cecilia Furlong
Stock Analyst at Morgan Stanley
(2.27)
# 1,669
Out of 4,479 analysts
166
Total ratings
41.25%
Success rate
-3.06%
Average return
Main Sectors:
Top Industries:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EMBC Embecta | Maintains: Underweight | $16 → $13 | $12.15 | +7.00% | 11 | May 10, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $150.19 | -36.75% | 12 | Feb 28, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $120 → $125 | $105.96 | +17.97% | 10 | Dec 4, 2023 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $6.31 | -36.61% | 13 | Dec 4, 2023 | |
| ISRG Intuitive Surgical | Maintains: Equal-Weight | $300 → $330 | $436.24 | -24.35% | 10 | Dec 4, 2023 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $77.12 | +27.07% | 9 | Nov 22, 2023 | |
| NVRO Nevro | Maintains: Equal-Weight | $23 → $18 | $8.61 | +109.06% | 7 | Nov 2, 2023 | |
| AXNX Axonics | Maintains: Overweight | $76 → $69 | $67.30 | +2.53% | 5 | Oct 31, 2023 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $149 → $135 | $106.45 | +26.82% | 13 | Oct 11, 2023 | |
| NARI Inari Medical | Reiterates: Overweight | $83 | $50.19 | +65.37% | 5 | Aug 3, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $88.07 | -3.49% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $25.45 | -41.06% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $196.16 | +74.86% | 3 | May 5, 2023 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $11 → $14 | $6.24 | +124.36% | 7 | May 3, 2023 | |
| BAX Baxter International | Maintains: Equal-Weight | $44 → $48 | $33.06 | +45.19% | 4 | Apr 28, 2023 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $102 | $90.25 | +13.02% | 8 | Apr 27, 2023 | |
| BSX Boston Scientific | Maintains: Overweight | $56 → $58 | $76.41 | -24.09% | 7 | Apr 27, 2023 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $18 → $20 | $14.59 | +37.08% | 5 | Feb 23, 2023 | |
| DXCM DexCom | Maintains: Equal-Weight | $117 → $131 | $112.17 | +16.79% | 7 | Jan 6, 2023 | |
| ABT Abbott Laboratories | Maintains: Overweight | $117 → $133 | $103.20 | +28.88% | 11 | Jan 6, 2023 | |
| SYK Stryker | Maintains: Equal-Weight | $270 → $220 | $336.50 | -34.62% | 4 | Jul 15, 2022 | |
| TFX Teleflex | Maintains: Equal-Weight | $383 → $378 | $211.44 | +78.77% | 2 | Feb 25, 2022 |
Embecta
May 10, 2024
Maintains: Underweight
Price Target: $16 → $13
Current: $12.15
Upside: +7.00%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $150.19
Upside: -36.75%
Zimmer Biomet Holdings
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $120 → $125
Current: $105.96
Upside: +17.97%
Sight Sciences
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $6.31
Upside: -36.61%
Intuitive Surgical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $300 → $330
Current: $436.24
Upside: -24.35%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $77.12
Upside: +27.07%
Nevro
Nov 2, 2023
Maintains: Equal-Weight
Price Target: $23 → $18
Current: $8.61
Upside: +109.06%
Axonics
Oct 31, 2023
Maintains: Overweight
Price Target: $76 → $69
Current: $67.30
Upside: +2.53%
iRhythm Technologies
Oct 11, 2023
Maintains: Overweight
Price Target: $149 → $135
Current: $106.45
Upside: +26.82%
Inari Medical
Aug 3, 2023
Reiterates: Overweight
Price Target: $83
Current: $50.19
Upside: +65.37%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $88.07
Upside: -3.49%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $25.45
Upside: -41.06%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $196.16
Upside: +74.86%
Pulmonx
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $6.24
Upside: +124.36%
Baxter International
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $33.06
Upside: +45.19%
Edwards Lifesciences
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $90.25
Upside: +13.02%
Boston Scientific
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $76.41
Upside: -24.09%
Bausch + Lomb
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $14.59
Upside: +37.08%
DexCom
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $112.17
Upside: +16.79%
Abbott Laboratories
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $103.20
Upside: +28.88%
Stryker
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $336.50
Upside: -34.62%
Teleflex
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $211.44
Upside: +78.77%